Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Pharmaceutical Statistics|October 13, 2012
The challenges of evaluating dose response in flexible-dose trials using marginal structural modelsIlya Lipkovich, Craig H Mallinckrodt, Douglas E Faries
Journal of Psychiatric Research|April 2, 2011
Recent developments in improving signal detection and reducing placebo response in psychiatric clinical trialsCraig H Mallinckrodt, Roy N Tamura, Yoko Tanaka
Journal of Biopharmaceutical Statistics|March 11, 2014
A multiple-imputation-based approach to sensitivity analyses and effectiveness assessments in longitudinal clinical trialsBirhanu Teshome Ayele, Ilya Lipkovich, Geert Molenberghs, et al.
Pharmaceutical Statistics|November 27, 2015
Nonparametric covariate adjustment in estimating hazard ratiosHonghua Jiang, Pandurang M Kulkarni, Yanping Wang, et al.
Psychopharmacology Bulletin|August 1, 2008
Addressing methodological issues in studying antidepressant onset efficacy using prespecified sensitivity analysesIlya Lipkovich, Craig H Mallinckrodt, Apurva Prakash, et al.
The Journal of Clinical Psychiatry|December 9, 2003
Duloxetine in the long-term treatment of major depressive disorderJoel Raskin, David J Goldstein, Craig H Mallinckrodt, et al.
Journal of Biopharmaceutical Statistics|April 5, 2014
Comparison of several multiple imputation strategies for repeated measures analysis of clinical scales: to truncate or not to?Ilya Lipkovich, Zbigniew Kadziola, Lei Xu, et al.
Journal of Psychiatric Research|November 7, 2008
Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scalesAnnouschka Laenen, Ariel Alonso, Geert Molenberghs, et al.
Psychopharmacology Bulletin|June 29, 2010
Signal detection and placebo response in schizophrenia: parallels with depressionCraig H Mallinckrodt, Lu Zhang, William R Prucka, et al.
Journal of Pharmacological and Toxicological Methods|June 24, 2010
Utility of positive controls in assessing assay sensitivity in ICH S7B and ICH E14 guidance for evaluation of QT/QTc interval prolongationAlan Y Chiang, Craig H Mallinckrodt, Alex A Dmitrienko, et al.
Pageof 6